Novel reagents for monitoring sulfation patterns in heparin and heparan sulfate
Ended Project Grant Awarded Last action
- Award ID
- R43GM136013
- Recipient
-
Lectenz Bio, Inc. UEI JTGCK219C6F4
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $893,381
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date
- Originally
- Funding
-
- $670,586.00 Federal
- $222,795.00 Non-federal
- Place of performance
- Georgia, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $222,795 | $0 | |
| Amendment | $222,795 | $222,795 | |
| Original award | $224,996 | $0 |
Quick answers
Who received award R43GM136013?
R43GM136013 was awarded to Lectenz Bio, Inc. by National Institute of General Medical Sciences (National Institutes of Health) on March 1, 2020.
How much is award R43GM136013 worth?
$893,381 has been obligated on R43GM136013: $670,586 in federal funding and $222,795 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award